Illumina partners with centers across France to advance a precision medicine approach for patients with late-stage cancer

/PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN), today announced an agreement with the Jean Perrin Center at the Clermont-Ferrand University Hospital in France to...

Related Keywords

France ,French ,Karen Birmingham ,Phil Febbo ,Jean Perrin ,Pascal Pujol ,Instagram ,Research Use ,French Society For Predictive ,Illumina Inc ,Jean Perrin Center ,Chief Medical Officer ,General Director ,Professor Pascal Pujol ,French Society ,Personalized Medicine ,Oncogenetics Department ,Montpellier University ,One Genomics ,Trusight Oncology ,Research Use Only ,Comprehensive Genomic Profiling ,Tumor Mutational Burden ,Microsatellite Instability ,Illumina ,Nc ,